CNMD | CONMED CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$46.59
+$2.30 (+5.19%)

CONMED Corporation (CNMD) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is above both.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
between the two $46.59 vs 50 $46.99 / 200 $41.43
Projection
No cross projected
Test
No active test
Last cross
Golden cross 14 Aug 2026 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $44.29 vs 50 $41.34 / 200 $71.04
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 5 Feb 2024 ยท projected 15 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $47.23 vs 50 $46.31 / 200 $44.53
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Jul 2026 ยท projected 24 bars out

Cross history

27
crosses on record since 2018
13 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
14 Aug 2026Golden steepdaily25 bars outNot tested
22 Jul 2026Golden4-hour24 bars outNot tested
16 Mar 2026Death4-hour27 bars outNot tested
9 Mar 2026Golden4-hour30 bars outNot tested
15 Sep 2025Death4-hour7 bars outโ€”

About CNMD

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$16.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.